Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Indiana for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Indiana only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Indiana (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Neil Finnen (NPI 1225014848)

Field	Value
Entity Type	Individual
Organization	Neil Finnen
Address	11220 Illinois St Ste 150
City	Carmel
State	IN
ZIP	46032
Taxonomy	Ophthalmology Physician
NPI Enumerated	December 15, 2005

Payer Source	Total Paid
Medicare	$1.9M
Medicaid	$0

Key Findings

This provider’s Medicare activity is concentrated in intravitreal biologic therapy: J0178 (aflibercept) and J2777 (faricimab) together account for the precomputed bulk of Medicare revenue—these two codes plus a third make up 84.1% of the provider's total Medicare revenue, indicating a service mix dominated by anti-VEGF and related intravitreal injections rather than predominantly office-based care or surgery. The presence of J3590 (unclassified biologics) as a smaller but notable line item further reinforces an infusion/injectable-focused practice model.

Revenue scale is meaningful at the Medicare level: the provider reports Total Medicare revenue of $1.9M while Medicaid revenue is none on file, so this clinician operates effectively as a single-payer (Medicare-centric) biller. The absence of any Medicaid billing on record suggests payer exposure and business risk are concentrated in the Medicare population and associated drug reimbursement channels.

Competitive standing on key drug codes is mixed: for J0178 the provider’s volume and revenue place them at rank #1040 of 3204 providers nationally (67th percentile), which is broadly in the typical national range and not dominant but consistent. For J2777 the provider ranks #537 of 2039 (74th percentile), again typical but slightly stronger versus peers, suggesting solid but not market-leading volume in faricimab administration.

Several codes show relatively high national percentile positions for non-procedural services: 99213 ranks at the 99th percentile (#4341 of 457151 providers) and 92134 ranks at the 97th percentile (#914 of 26868 providers). These placements indicate unusually high outpatient E/M and retinal imaging volume relative to national peers, consistent with a high-throughput clinic supporting frequent follow-up and diagnostic imaging for medical retina patients receiving injections.

Procedure-level surgical volume is present but limited: vitreoretinal surgical codes such as 67036, 67108, and 67041 appear with modest claim counts and sit in mid-to-upper percentile ranks (82nd, 77th, and 56th percentiles respectively), indicating the provider performs some surgical retinal work but that surgery is a minor contributor to overall revenue compared with intravitreal drug administration. Surgical CPTs account for small individual revenue shares (each ~1% of Medicare revenue).

There are statistical outliers worth noting in utilization patterns: several codes are flagged at high percentile levels — 99213 is an "extreme outlier, far above typical national volume," and 92134 is "notably above typical national volume," which signals unusually heavy use of office visits and OCT imaging relative to most providers. Conversely, commonly used drug codes such as J3590 are "notably above typical national volume" for a small group of providers, placing this clinician in a concentrated subset that bills unclassified biologics more frequently than most peers.

Tenure is long: the NPI was enumerated on 2005-12-15 (about 21 years ago), indicating an established practice with sustained Medicare billing history. This longevity supports interpretation of the observed service mix as stable rather than a short-term fluctuation.

Given the code mix and revenue concentration, the business model appears centered on ongoing retinal medical management—repeated office visits, OCT imaging (92134), and high-volume intravitreal injections (J0178, J2777) drive the economics of the practice. Payers and network managers should therefore treat this provider as a high-volume medical retina/ophthalmology outpatient clinic with limited Medicaid exposure and a heavy reliance on Medicare drug reimbursement channels.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

19 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	1,260	$690	$871.9K
J2777	Injection, faricimab‑svoa, 0.1 mg	19,800	$30	$574.2K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,440	$90	$122.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	1,170	$60	$67.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,130	$30	$57.6K
J3590	Unclassified biologics	620	$70	$42.8K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	180	$160	$28.9K
67036	The provider removes vitreous fluid from the eye to access the posterior segment of the eye and introduce surgical instruments through incisions in the pars plana.	40	$650	$22.6K
67108	The provider repairs a detached retina using heat produced by a laser beam or by freezing the tissues. He may attach a scleral buckle to simplify the passage of fluid through and behind the retina or…	30	$810	$20.1K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	20	$840	$15.9K

Showing 1–10 of 19

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 19 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Indiana Distribution

Neil Finnen — 2 of 19 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Indiana

Full comparison — all codes billed, vs. state median

19 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	22	60	830	$690	$868.8K
J2777	10	40	6,750	$30	$395.6K
67028	21	80	550	$80	$78.6K
J7312	5	10	280	$160	$47.7K
67036	5	10	30	$1,040	$37.4K
67108	4	20	20	$1,150	$32.2K
J3590	13	50	220	$60	$24.5K
67041	5	10	20	$1,000	$22K
J9035	32	30	200	$50	$19.2K
92235	16	40	90	$100	$15.8K

Showing 1–10 of 19

Related Providers

Other providers that share a Tax Identification Number (TIN) with Neil Finnen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Khaled Tawansy	CA	Ophthalmology Physician	$2.8M	$2.4M
Victor Shi	CA	Vascular & Interventional Radiology Physician	$2.2M	$280
Pejman Shirazy	CA	Pain Medicine (Physical Medicine & Rehabilitation) Physician	$1.9M	$3.7K
Haris Zahoor	TX	Medical Oncology Physician	$1.6M	$0
Carl Rossi	CA	Radiation Oncology Physician	$1.6M	$0
Richard Abello	CA	Diagnostic Radiology Physician	$1.5M	$0
Samuel Kim	CA	Retina Specialist (Ophthalmology) Physician	$1.5M	$0
George Semeniuk	CA	Hematology & Oncology Physician	$1.5M	$0
Nasim Daoud	NV	Rheumatology Physician	$1.3M	$0
Michael Booker	CA	Diagnostic Radiology Physician	$1.2M	$0

Nearby Providers

Other providers in the same ZIP code as Neil Finnen, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Aspire Indiana Inc.	IN	Mental Health Clinic/Center (Including Community Mental Health Center)	$0	$26.2M
Landmark Recovery Of Carmel LLC	IN	Substance Abuse Rehabilitation Facility	$0	$26.2M
Little Star Center, Inc.	IN	Early Intervention Provider Agency	$0	$22.7M
Arrow Consultation Services, Inc.	IN	Developmentally Disabled Services Day Training Agency	$0	$10.5M
Indiana University Health North Hospital Inc	IN	General Acute Care Hospital	$0	$6.9M
Option Care Enterprises, Inc.	IN	Home Infusion Therapy Pharmacy	$0	$5.2M
Impact Physician Group, Indiana LLC	IN	Internal Medicine Physician	$0	$4.2M
Westmed, LLC	IN	Durable Medical Equipment & Medical Supplies	$0	$4M
Chinthala, PC	IN	Psychiatry Physician	$0	$3.9M
American Health Network Of Indiana, LLC	IN	Clinical Medical Laboratory	$2.2M	$1.6M

Neil Finnen — Billing Profile & Reimbursement Data

Sign up for Neil Finnen — Billing Profile & Reimbursement Data policy alerts

Neil Finnen — Billing Profile & Reimbursement Data

Sign up for Neil Finnen — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References